General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Regeneron(MODEST), CSL Behring(SIGNIFICANT), Madrigal(SIGNIFICANT), CiVi Biopharma(SIGNIFICANT), Esperion Therapeutics(SIGNIFICANT), North Sea Therapeutics(MODEST), Draupnir(SIGNIFICANT), Pfizer(MODEST), Novartis(MODEST), Omeicos(SIGNIFICANT), Silence Therapeutics(SIGNIFICANT), Sirnaomics(SIGNIFICANT) OFFICER, DIRECTOR ETC: NewAmsterdam Pharma(SIGNIFICANT), Staten Biotech(SIGNIFICANT)

View Full Disclosure